Sacituzumab govitEcan in THYroid Cancers
Sacituzumab govitEcan in THYroid Cancers
Recruiting · NCT06235216 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sacituzumab govitEcan in THYroid Cancers | Neoplasms by Histologic Type, carcinoma, differentiated thyroid carcinoma, epithelial neoplasm, neoplasm, thyroid gland undifferentiated (anaplastic) carcinoma | Recruiting | Phase 2 | 2026-09-16 | NCT06235216 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
| Grupo Espanol de Tumores Neuroendocrinos | 4 |
| MFAR | 9 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Complexo Hospitalario Universitario de Ferrol | Ferrol | Spain | 1 |
| H.U. Marqués de Valdecilla | Santander | Spain | 1 |
| Hospital Clínico San Carlos | Madrid | Spain | 30 |
| Hospital General Universitario Morales Meseguer | Murcia | Spain | 11 |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | 1 |
| Hospital Universitario Central De Asturias | Oviedo | Spain | 25 |
| Hospital Universitario La Paz | Madrid | Spain | 75 |
| Hospital Universitario Miguel Servet | Zaragoza | Spain | 27 |
| Hospital Universitario Ramón y Cajal | Madrid | Spain | 42 |
| Institut Catala d´Oncologia (ICO) -Hospitalet | Hospitalet de Llobregat (Barcelona) | Spain | 1 |
| MD Anderson Cancer Center Madrid | Madrid | Spain | 7 |